-
Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
Author: Rashidian, Houman; Subramaniapillai, Mehala; Park, Caroline; Lipsitz, Orly; Zuckerman, Hannah; Cao, Bing; Lee, Yena; Gill, Hartej; Rodrigues, Roger Nelson; Di Vincenzo, Joshua D.; Iacobucci, Michelle; Jaberi, Saja; Rosenblat, Joshua D.; McIntyre, Roger S.; Mansur, Rodrigo B.
Journal: JOURNAL OF PSYCHOPHARMACOLOGY. 2023; Vol. 37, Issue 3, pp. 313-317. DOI: 10.1177/02698811221132473
-
Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
Author: Chang CH1,2, Lane HY1,2,3,4, Tseng PT5,6, Chen SJ7,8, Liu CY9, Lin CH1,3,10.
Journal: J Psychopharmacol. 2019 Apr;33(4):436-448. doi: 10.1177/0269881118822157. Epub 2019 Feb 7.
-
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder.
Author: Zheng W1, Zhou YL1, Liu WJ1, Wang CY1, Zhan YN1, Li HQ1, Chen LJ1, Li MD1,2, Ning YP1.
Journal: J Psychopharmacol. 2019 Apr;33(4):494-501. doi: 10.1177/0269881119827811. Epub 2019 Feb 21.
-
Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.
Author: Chen L1, Cui S2,3, Yu H2, Li G2, Liu N2, Wu Q4, Zhang HT4, O'Donnell JM2, Wang G1, Xu Y2.
Journal: J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.
-
Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial.
Author: Lin CH1,2,3, Chen PK4,5, Wang SH6, Lane HY2,7,8.
Journal: J Psychopharmacol. 2019 May 22:269881119849815. doi: 10.1177/0269881119849815. [Epub ahead of print]
-
NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects.
Author: Zuiker RG, Chen X, Østerberg O, Mirza NR, Muglia P, de Kam M, Klaassen ES, van Gerven JM.
Journal: J Psychopharmacol. 2016 Mar;30(3):253-62. doi: 10.1177/0269881115620435. Epub 2015 Dec 10.
-
Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216.
Author: Zhang LM, Qiu ZK, Chen XF, Zhao N, Chen HX, Xue R, Zhang YZ, Yang RF, Li YF.
Journal: J Psychopharmacol. 2016 May;30(5):474-81. doi: 10.1177/0269881115625115. Epub 2016 Jan 18.
-
Anxiolytic effects of GLYX-13 in animal models of posttraumatic stress disorder-like behavior.
Author: Jin ZL, Liu JX, Liu X, Zhang LM, Ran YH, Zheng YY, Tang Y, Li YF, Xiong J.
Journal: J Psychopharmacol. 2016 May 4. pii: 0269881116645298. [Epub ahead of print]
